The Honorable Tina Brozman Foundation, Inc. 2010 Annual Report About Tina’s Wish
Tina Brozman’s impact as a jurist, lawyer, mentor, wife, mother and friend cannot be underestimated. An internationally known trailblazer in the field of insolvency, Tina served as the chief judge of the United States Bankruptcy Court for the Southern District of New York prior to stepping down from the bench to become a partner with the global law firm Bingham McCutchen. She co-chaired the firm’s financial restructuring practice until her death in June 2007 at age 54 from ovarian cancer.
Tina’s lasting contributions as a bankruptcy scholar and advocate can be seen today in the work of the many judges and lawyers she mentored throughout her career as well as in the domestic and international bankruptcy jurisprudence on which she had such a profound influence. As she battled late-stage ovarian cancer in the last two years of her life, Tina brought her passion, drive and intellect to a new and even more challenging realm: the search for an early screen for ovarian cancer. Tina’s deep commitment to others, her unselfishness and her uncanny knack for leaving every person and every issue she touched better than she found them live on in the work of Tina’s Wish. Knowing it was too late to affect her own survival, Tina nevertheless undertook the critical and selfless work of saving the lives of other women. It is this work that the Honorable Tina Brozman Foundation pursues in her name, in her honor and in her spirit.
1 Tina’s Wish — Annual Report 2010 Tina’s Wish — Annual Report 2010 2 A Message From the Chair of the Board
Tina’s Wish had a productive year in 2010. As a volunteer-led organization, we are proud of what we have been able to accomplish with a group of busy people working in their spare time. We are extremely grateful for the help and support of all of our friends — you have made our success to date possible. We all still hear Tina’s voice, urging us on to accomplish more.
The mission of Tina’s Wish remains simple, though not easy: to find an effective early detection test for ovarian cancer. This mission will continue to push us until we can say that Tina’s Wish has been fulfilled — that other women who are diagnosed with ovarian cancer do not face the outcome Tina faced. As you have heard from us before, early detection is key to the effective treatment and cure of ovarian cancer and is all too rarely the case today. Ovarian cancer survival rates have barely improved over the past 30 years, largely because early detection remains elusive.
This reality is a call to action. We have seen some impressive work by the outstanding researchers we support at Yale and Penn, and we plan to do more in 2011 to support promising ovarian cancer research. A brief description of some of that work is included in this report. This year, we are reaching out for additional expert advice on programs and research to support, with a continued view to identifying those areas where our dollars can have the most significant impact.
As we work to plan our next Tina’s Wish Benefit Dinner for this coming fall, we are very pleased to let you know that this year’s Tina Brozman Mentoring Award recipient is Arthur Newman. Arthur was a close friend of Tina’s and a caring and effective mentor for those who worked with him. While we are sad to have to present the award posthumously, we are also very proud of the role Arthur played in mentoring Tina’s Wish; his leadership was an early catalyst for our organization’s planning and fundraising efforts. We will keep you informed as our planning efforts proceed and hope to see you at this year’s event.
We want to take this opportunity to thank each one of our friends and supporters — only with your help can we achieve our goals.
Amy L. Kyle, Chair
3 Tina’s Wish — Annual Report 2010 The Board of Directors
The Honorable Tina Brozman Foundation
Andrew Brozman Julia Frost-Davies Michael J. Reilly Director Treasurer and Director Director
Paul Cleary Amy L. Kyle Jack Bode Director President and Director Executive Consultant to the Board
Jennifer C. DeMarco Hon. Cecelia G. Morris Director Director
Board and Honorees: Tina’s Wish Benefit Dinner Back row (l-r) Michael J. Reilly, Elizabeth Reilly, Andrew Brozman, Amy L. Kyle, Paul Cleary, Jennifer C. DeMarco, Julia Frost-Davies Front row (l-r) Hon. Cecelia G. Morris, Prof. Elizabeth Warren, Hon. Burton R. Lifland, Elaine Lifland
Tina’s Wish — Annual Report 2010 4 Your Dollars in Action
Searching for Answers at Yale
One of the most persistent hopefully lead to earlier and challenges in the battle against more effective treatment ovarian cancer arises from the options that could block tumor lack of an effective method progression and prevent to detect the disease at an recurrence, metastasis and early stage. Many women, like resistance to chemotherapy. Tina, are thus diagnosed with ovarian cancer only when it has “The major treatment obstacle progressed to a more advanced in the treatment of ovarian and aggressive stage at which cancer is the lack of sensitive treatment options are more approaches that would allow limited. Tina believed we can — the early detection of ovarian and must — do better. cancer as well as adequate monitoring of the disease to At the Yale School of Medicine/ prevent recurrence,” says Dr. Yale Cancer Center, a grant Mor. “The support from the from the Honorable Tina foundation has been critical Brozman Foundation funds to the advancement of our the work of Dr. Gang Yin, a research and the professional postdoctoral fellow who is development of Dr. Yin.” working under the guidance of Dr. Gil Mor to isolate and With your help, the grant identify the cellular origins of provided by the Honorable ovarian cancer in a quest to Tina Brozman Foundation to develop new strategies for early support the work of Dr. Mor detection and treatment. Using and his team promotes the twin epithelial ovarian cancer stem goals of providing resources cells, Dr. Yin has identified the for the investigation of early transcription factor that controls detection strategies while also the process of differentiation, encouraging promising medical tumor progression and professionals to enter the field. metastasis, which may be With each doctor who joins the helpful in identifying a tumor battle against ovarian cancer, marker to serve as an early and with every day spent indicator in diagnosing and working toward early detection predicting the progression and effective intervention, we of ovarian cancer. This will are closer to making Tina’s wish a reality.
5 Tina’s Wish — Annual Report 2010 Dr. Gil Mor
Tina’s Wish — Annual Report 2010 6 Your Dollars in Action
Molecular Imaging and Tumor Investigation at Penn
With the support of the Using innovative antibody Honorable Tina Brozman libraries and new Foundation, a team at the methodologies, Penn University of Pennsylvania investigators have developed Ovarian Cancer Research antibodies against the first Center under the leadership of of these new tumor vascular Dr. George Coukos has been markers. In preclinical working to develop strategies experiments, tumors can now for the early detection of be visualized with a PET scan ovarian cancer through imaging using a radiolabeled antibody tumor vasculature. with a high degree of sensitivity and specificity. The team will Using cutting-edge molecular be extending this work into techniques developed in his additional markers and imaging laboratory, Dr. Coukos and approaches that are suitable his team identified unique for the early clinical detection proteins expressed by the of ovarian cancer such as ovarian cancer vasculature. ultrasound and laparoscopy- Because these molecules are assisted optical imagery, with bound to the surface of tumor the hope of continuing their blood vessels, they can be progress toward developing an targeted to visualize tumors effective screen that can be through molecular imaging. made available to women and This approach generates their doctors for early diagnosis, unique opportunities for the treatment and improved development of early detection outcomes. of ovarian cancer because blood vessels of tumors are molecularly different than normal blood vessels and these molecular changes occur at the occult stage of tumors.
7 Tina’s Wish — Annual Report 2010 Dr. George Coukos
Tina’s Wish — Annual Report 2010 8 Celebrating Tina’s Life and Legacy
The Honorable Tina Brozman Mentoring Award
Consistent with her lifetime of not only his lasting impact on As the bankruptcy bench and giving, Tina Brozman believed bankruptcy jurisprudence but bar gathered to celebrate Tina strongly in investing in the next also his service as a mentor Brozman’s life and legacy, generation and in the power to a generation of judges they had the opportunity to of mentoring. In her honor, and lawyers, including Tina recognize Professor Warren’s and to celebrate her legacy, Brozman. It was fitting not only extraordinary contributions Tina’s Wish established the that Judge Lifland received the to mentoring and to the Tina Brozman Mentoring first Tina Brozman Mentoring development of bankruptcy Award to recognize outstanding Award but also that he scholars and practitioners. contributions to mentoring, presented this year’s award to The chief adviser to the teaching and leadership. Professor Elizabeth Warren, the National Bankruptcy Review Leo Gottlieb Professor of Law at Commission and the first The first recipient of the Harvard University, at the Tina’s academic member of the award was the Hon. Burton R. Wish Benefit Dinner held on Federal Judicial Education Lifland, an outstanding jurist September 22, 2010. Committee, Professor Warren whose contributions include
Professor Elizabeth Warren and Hon. Burton R. Lifland
9 Tina’s Wish — Annual Report 2010 has had a profound influence herself to advance others. Tina’s practice, a committee made up on the national approach to Wish was honored to present of luminaries of the bankruptcy issues dealing with credit and her with the 2010 Tina Brozman bar hosted a spectacular dinner economic stress. Through Mentoring Award. in New York. The evening her own work, which includes provided an opportunity to hear nine books and more than 100 In addition to providing an from medical professionals on scholarly articles, as well as the opportunity to celebrate the the front lines of the fight against ongoing efforts of the students passion for mentoring shared ovarian cancer, to celebrate under her tutelage, Professor by Tina, Professor Warren Tina’s life, and to recognize Warren, like Judges Lifland and and Judge Lifland, the Tina’s others such as Professor Warren Brozman, has made a significant Wish Benefit Dinner brought who continue her legacy of and unique contribution to the together numerous friends, a passion for education and national conversation on these colleagues and supporters of the law. As a result of the issues and on a generation of the foundation in their collective generous donations of firms judges, lawyers and students. fight against ovarian cancer. and individuals throughout the A friend and colleague of Tina Under the leadership of Michael community, the Tina’s Wish Brozman’s, Professor Warren J. Reilly, Tina’s partner at Benefit Dinner raised over shares her commitment to the Bingham and co-chair of the $625,000 to be deployed to next generation and gives of firm’s financial restructuring making Tina’s wish a reality.
Tina’s Wish — Annual Report 2010 10 Tina’s Wish Benefit Dinner
A Special Thanks to the Organizing Committee
Akin Gump Strauss Dewey & LeBoeuf LLP Skadden, Arps, Slate, Hauer & Feld LLP Martin J. Bienenstock Meagher & Flom LLP Daniel H. Golden John Wm. (Jack) Butler, Jr. Fried, Frank, Harris, Jay M. Goffman AlixPartners LLP Shriver & Jacobson LLP J. Gregory Milmoe Lisa J. Donahue Brad Eric Scheler Alan N. Resnick Togut, Segal & Segal LLP Alvarez & Marsal Gary L. Kaplan Albert Togut Bryan Marsal Houlihan Lokey Wachtell, Lipton, Rosen & Katz Bingham McCutchen LLP Howard & Zukin Harold S. Novikoff Michael J. Reilly David Hilty Weil Gotshal & Manges LLP Blackstone Kirkland & Ellis LLP Marcia L. Goldstein Arthur J. Newman Richard Cieri Harvey R. Miller Timothy Coleman James H.M. Sprayregan Stephen Karotkin
Table Sponsors
Brown Rudnick LLP Greenberg Traurig LLP Rothschild Ed Weisfelner Bruce Zirinsky David Resnick Todd Snyder Capstone Advisory Group Hahn & Hessen LLP Neil Augustine Ed Ordway Mark Power Homer Parkhill
Clifford Chance Latham & Watkins LLP Simpson Thatcher & Andrew Brozman Robert Rosenberg Bartlett LLP Peter Pantaleo Davis Polk & Wardwell LLP Milbank, Tweed, Don Bernstein Hadley & McCloy LLP Stroock Stroock & Lavan LLP Dennis Dunne Lawrence Handelsman Dechert LLP Mike Sage Miller Buckfire White & Case LLP Eric Brunstad Henry Miller Evan Hollander
FTI Consulting, Inc. Morrison Foerster LLP Zolfo Cooper Dewey Imhoff Gary Lee Joff Mitchell
General Electric Company Otterbourg, Steindler, Houston & Rosen, P.C. Brackett Denniston Scott Hazan
11 Tina’s Wish — Annual Report 2010 Professor Elizabeth Warren with Alix and Andrew Brozman
Tina’s Wish thanks the Judges of the United States Bankruptcy Court, Southern District of New York, for their friendship and support.
The Hon. Arthur J. Gonzalez, Chief Judge The Hon. Allan L. Gropper The Hon. Stuart M. Bernstein The Hon. Sean H. Lane The Hon. Shelley C. Chapman The Hon. Burton R. Lifland The Hon. Robert D. Drain The Hon. Cecelia G. Morris The Hon. Robert E. Gerber The Hon. James M. Peck The Hon. Martin Glenn
A special thank you to the Estate of Patricia A. Binetti for the extraordinary support and generosity in helping to make Tina’s Wish come true.
Tina’s Wish — Annual Report 2010 12 Income*
$ 625,000 Tina’s Wish Fall 2010 Dinner
$ 327,422 Other
Expenses*
$ 396,388 2011 Grant Reserve
$ 320,000 2010 Grants
$ 137,952 Annual Dinner
$ 50,000 Operating Expense Reserve
$ 33,220 Administrative
$ 9,427 Donor Outreach
$ 5,435 Accounting
* Unaudited 2010 numbers. Audits for 2008-2009 available upon request.
13 Tina’s Wish — Annual Report 2010 Thanks to Our Generous Donors in 2010
Tina’s Wish thanks our generous donors whose support makes our work possible.
Akin Gump Strauss Hauer & Feld LLP Scott A. Falk and Anna M. Boelitz Thomas E. and Paula N. Kurth Rothschild AlixPartners LLP Irene Filipiuk David Kurtz Jeffrey S. and Evelyn L. Sabin Jonathan B. Alter and Marci B. Alter Daniel F. and Carrie Ann Fiorillo Kurtzman Carson Consultants, LLC Edward Oppenheimer and Wendy Ann Sassower Alvarez & Marsal Theodore L. Freedman Amy L. Kyle and Alfred O. Rose Anup and Karyn M. Sathy A. Philip Auerbach and Fried, Frank, Harris, Shriver & Jacobson Daniel M. and M. Natasha Labovitz Stephanie Ross Auerbach LLP Robert H. Scheibe Jonathan M. and Gary E. Axelrod Ira Frome Sandra A. Riemer Landers Margot B. Schonholtz and Gerald D. Pietroforte D.J. (Jan) Baker and Julia Frost-Davies and Jason Davies Sandy Laskin Suzanne Baker Ray C. and Anne E. Schrock FTI Consulting, Inc. Latham & Watkins LLP Jenette A. Barrow-Bosshart Roger G. Schwartz F. Mark Fucci Lazard Freres & Co., LLC Paul M. Basta and Mitchell A. Seider and Lisa R. Beck Stephanie Oratz Basta Diane Gallagher Shirley F. Lesser & Richard M. Lesser David R. Seligman Carol A. Beck The Garden City Group Inc. Richard & Kathleen Levin Joseph Serino, Jr. Jay H. Berg Holland O’Neil, Gardere Steve Levitan Wynne Sewell LLP Raymond and Judith M. Shapiro Bingham McCutchen LLP Alan Levy James L. Garrity, Jr. Stephen J. Shimshak Estate of Patricia A. Binetti Andrew D. and Deborah Swartz Lipman Ashley S. Gregory Ronald J. and Cheryl Silverman Carl S. Bjerre and Andrea Coles-Bjerre Ralph and Sylvia Mabey General Electric Company William M. and Lynn G. Silverman Blackstone Judith R. MacDonald Daniel M. and Merrily Glosband Keith A. Simon and Ami L. Collard Blank Rome LLP Stephanie W. Mai Shon Glusky Simpson Thacher & Bartlett LLP M.R. Bonner Christopher J. Marcus Daniel H. and Kerry G. Golden Martin and Susan Siroka Nader and Sarah Boulos Carl Marks Advisory Group LLC Goldin Associates, LLC Skadden, Arps, Slate, Gary A. Brooks Robert D. and Ruth A. Martin Meagher & Flom LLP Marie N. and Arthur J. Gonzalez Mark Broude Gregory & Rosanne Matzat Bernice L. Slotnick Barbara Gottlieb Brown Rudnick Erin K. Mautner Ed Smith and Kitty Smith Greenberg Traurig LLP Andrew P. Brozman McGuireWoods LLP Steven B. and Katherine Forman Soll Donald L. and Rosalie W. Gray Karen Campbell Mark and Kelly H. McKane Solow & Co., Inc. Hahn & Hessen LLP Capstone Advisory Group, LLC Milbank Memorial Fund James and Tracy Sprayregen Bruce D. Haims Richard M. and Cherylyn A. Cieri Milbank, Tweed, Hadley & McCloy LLP Arthur Steinberg Halperin Battaglia Raicht, LLP Jared R. Clark Miller Buckfire & Co., LLC James A. and Julie K. Stempel Judith Elkin, Haynes and Boone Cleary Gottlieb Steen & Hamilton LLP Morrison & Foerster LLP Stillman, Friedman & Shechtman P.C. Robert and Elizabeth R. Hayward Paul D. Cleary The Morrison & Foerster Foundation Stroock Stroock & Lavan LLP Scott L. and Lorraine Hazan Clifford Chance US LLP Dennis M. and Linda Myers Enid Nagler Stuart and Mitchell Stuart Jonathan N. and Robin E. Helfat Evan and Tammy Cohen Christian O. Nagler Albert Togut Jonathan S. and Pamela K. Henes Judith Lynne Cohen Patrick J. Nash, Jr. Togut, Segal & Segal LLP Houlihan Lokey Howard & Zukin Conway Del Genio Gries & Co., LLC Jaimie Nathanson Lisa Valentovish Janice Howe Michael Cook John M. and Charlotte Newman, Jr. Vinson & Elkins L.L.P. Yongjin and Jisso Im Keith S. Crow The Eileen and Arthur Newman Wachtell, Lipton, Rosen & Katz Jefferies & Company, Inc. Family Foundation Melanie L. Cyganowski and Mitchell and Barbara Wand Kenneth L. LeBrun David O. and Mary Hynes Johanson Howard S. Novikoff Weil, Gotshal & Manges LLP Jeffrey K. Cymbler Lori Lapin Jones PLLC Otterbourg, Steindler, Houston & Rosen, P.C. Katherine Weinstein Matthew Daniele Roger P. Joseph Richard Paige Jay L. and Pauline Westbrook Davis Polk & Wardwell LLP Jason S. and Mara F. Kanner Adam C. and Michelle C. Paul White & Case LLP George A. and Karen Davis Marc and Heidi Holland Kieselstein David M. Posner and Lori A. Shay L. Tracee Whitley Dechert LLP Carole Kilpatrick Rebecca J. Rahn Bettina M. Whyte Jennifer C. DeMarco Kirkland & Ellis LLP John Rapisardi Steven and Rivkah A. Wilamowsky Dewey LeBoeuf LLP Joshua N. and Nancy E. Korff Linda Ray P. Sabin and Marta Willett DiConza Traurig Magaliff LLP Alan W. Kornberg Michael J. and Elizabeth Kennedy Reilly David Wollmuth Daniel T. Donovan Larry Kotler Glenn B. Rice Zolfo Cooper David L. Eaton Andrew W. and Amy L. Kramer Rosen & Associates, P.C. David Zott Ken Epstein Kramer Levin Naftalis & Frankel LLP Robert J. Rosenberg Evercore Partners Services East LLC Kristine Krol, MD, PA
Tina’s Wish — Annual Report 2010 14 Ovarian Cancer: The Facts
A deadly disease
• Ovarian cancer is the most deadly of gynecological cancers. Over 20,000 women are diagnosed each year with ovarian cancer and more than 15,000 women die.
No test for early diagnosis
• At present, no accurate, reliable test exists to diagnose ovarian cancer at an early stage.
• With early diagnosis and treatment, the five-year survival rate increases to about 94 percent.
A silent killer
• Ovarian cancer is rarely diagnosed in its early stages because its symptoms (which include abdominal bloating, difficulty eating and urinary symptoms) are often vague and non-specific.
• Seventy-five to eighty percent of women are diagnosed in later stages when the cancer has spread beyond the ovaries and the chance of survival is poor (fewer than 20 percent of those diagnosed at stage IV survive for five years).
Tina’s Wish thanks Deena Fazzio, Robert Geranis, Nancy Keenan, Nancy MacDonald, and Pam Richard for their generous contribution of time and talent in supporting our efforts.
Contributions to help make Tina’s wish come true may be made to:
The Honorable Tina Brozman Foundation, Inc. c/o Amy L. Kyle One Federal Street 30th Floor Boston, MA 02110 or by visiting us at tinabrozmanfoundation.org
The Honorable Tina Brozman Foundation is a Section 501 (c)(3) charitable organization. For more information, please contact [email protected].